In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality

Mark H. Ebell

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalAmerican family physician
Volume96
Issue number7
StatePublished - Oct 1 2017
Externally publishedYes

Fingerprint

Vascular Diseases
Mortality
AMG 145

ASJC Scopus subject areas

  • Family Practice

Cite this

In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality. / Ebell, Mark H.

In: American family physician, Vol. 96, No. 7, 01.10.2017.

Research output: Contribution to journalArticle

@article{ff61c53f6fa6490e99a2c8cd67c8cdc9,
title = "In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality",
author = "Ebell, {Mark H.}",
year = "2017",
month = "10",
day = "1",
language = "English (US)",
volume = "96",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "7",

}

TY - JOUR

T1 - In Very High-Risk Patients with Vascular Disease, Evolocumab Slightly Reduces Nonfatal MI But Not Mortality

AU - Ebell, Mark H.

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85064846167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064846167&partnerID=8YFLogxK

M3 - Article

C2 - 29094916

AN - SCOPUS:85064846167

VL - 96

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 7

ER -